A real world retrospective analysis of comparison of effectiveness and safety of mometasone furoate and fluticasone propionate in the management of eczema and dermatitis

---

Original Article

Author Details : R D Kharkar, Dhiraj Dhoot*, Harshal Mahajan, Hanmant Barkate

Volume : 7, Issue : 2, Year : 2021

Article Page : 120-124

https://doi.org/10.18231/j.ijced.2021.023

Suggest article by email

Get Permission

---

Abstract

Introduction: Contact dermatitis is one the commonest dermatological condition which is managed by topical corticosteroids. Mid potent topical corticosteroids are commonly prescribed but there is no any comparative data between mometasone furoate and fluticasone propionate in the management of dermatitis.
Materials and Methods: A real world retrospective study was conducted across India to compare the clinical assessment of mometasone 0.1% cream and fluticasone 0.005% cream in the management of contact dermatitis at 236 dermatology clinics.
Results: A data of 1106 patients were included in this analysis in which 598 were included in mometasone group while 508 in fluticasone group. At the end of 2 weeks, 216 patients (36.1%) in mometasone and 129 patients (25.4%) in fluticasone group achieved complete clearance of symptoms (p<0> Conclusion: Both, mometasone furoate and fluticasone propionate were effective and safe in treatment of eczema/dermatitis. But mometasone furoate had shown significantly better effectiveness as compared to fluticasone in all predisposing factors for the disease.

Keywords: Dermatitis, Mometasone, Fluticasone, Real world.

How to cite : Kharkar R D , Dhoot D , Mahajan H , Barkate H , A real world retrospective analysis of comparison of effectiveness and safety of mometasone furoate and fluticasone propionate in the management of eczema and dermatitis. IP Indian J Clin Exp Dermatol 2021;7(2):120-124

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.